Search results
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 1 day agoThanks to soaring sales of multiple new treatments, big gains are the new normal for Eli Lilly....
These Are the Drugs America Is Running Short On
247wallst.com· 6 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
What is dementia? Types, symptoms, causes and treatment
The Telegraph via Yahoo News· 1 hour agoBy the year 2040, there will be 1.7 million people in the UK living with dementia, according to the...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 6 days agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Eli Lilly lifts 2024 sales view by $2 billion on weight-loss drug demand By Reuters
Investing.com· 5 days agoFood and Drug Administration's website. Lilly said its raised forecast reflects "greater clarity...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 2 days agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 5 days agoIt also notified the FDA that it disputes the patent listings. The letters targeted what agency...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Houston Chronicle· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Novo nabs over a third of diabetes market, a year ahead of schedule
Endpoints News· 3 days agoNovo Nordisk’s GLP-1 drugs may have been the center of attention during its first-quarter earnings...